Citigroup
AYLA

Citigroup’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Citigroup’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-407,011
Closed -$444K – 6576
2022
Q2 		$444K Buy
+407,011
New +$930K ﹤0.01% 3314

Other funds holding AYLA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Citigroup's AYLA Position: Q3 2022 in Review

Citigroup sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q3 2022, closing a stake of 407,011 shares — an estimated $444K sold.

Citigroup first reported a position in AYLA in Q2 2022 and held it in 1 quarter. The position peaked at $444K in Q2 2022. 14 funds tracked by Wall St. Rank hold AYLA as of Q3 2022.

  • Citigroup reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 407,011 Ayala Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $444K.
  • Citigroup first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Citigroup's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $444K in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.